Skip to main content

Klotho Neurosciences

Omaha, United States

Klotho Neurosciences develops disease modifying therapies for age-related cognitive and neurodegenerative disorders and cancer.

$11.0M raised
Jun 2025
Post-IPO Equity

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Klotho Neurosciences

How much funding has Klotho Neurosciences raised?
Klotho Neurosciences has raised $11.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in June 2025.
Who are Klotho Neurosciences's investors?
Klotho Neurosciences's investors include Gaensel Energy Group.
Where is Klotho Neurosciences headquartered?
Klotho Neurosciences is headquartered in Omaha, United States.
What does Klotho Neurosciences do?
Klotho Neurosciences develops disease modifying therapies for age-related cognitive and neurodegenerative disorders and cancer.
What stage is Klotho Neurosciences at?
Klotho Neurosciences is at the Post-IPO Equity stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Klotho Neurosciences — Funding & Investors." VCBacked, June 16, 2025, https://www.vcbacked.co/company/klotho-neurosciences. Accessed July 2, 2026.
APA
VCBacked. (2025). Klotho Neurosciences — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/klotho-neurosciences
Wikipedia (cite web)
{{cite web |title=Klotho Neurosciences — Funding & Investors |url=https://www.vcbacked.co/company/klotho-neurosciences |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .